Erschienen in:
01.07.2013 | Letter to the Editor
RE: Acute myeloid leukemia associated with FGFR1 abnormalities
verfasst von:
John Jeongseok Yang, Seung Hwan Oh, Claus Meyer, Rolf Marschalek, Tae Sung Park
Erschienen in:
International Journal of Hematology
|
Ausgabe 1/2013
Einloggen, um Zugang zu erhalten
Excerpt
We have read with great interest the article entitled ‘Acute myeloid leukemia associated with
FGFR1 abnormalities’ by Lee et al. [
1]. As mentioned, clonal eosinophilic disorders related with abnormalities of
PDGFRA, PDGFRB, and
FGFR1 are a newly emphasized entity in the ‘2008 WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues’ [
2]. The myeloid and lymphoid neoplasms with eosinophilia and
FGFR1 abnormality, previously known as ‘8p11 myeloproliferative syndrome (EMS),’ [
3] is a disease with poor prognosis, which presents in various forms of hematologic malignancies and requires rigorous, close clinical monitoring after diagnosing this disease form, as previous reports of EMS describe rapidly changing disease courses under certain circumstances [
4]. …
